These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22069477)

  • 41. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis.
    Fujii T; Le Du F; Xiao L; Kogawa T; Barcenas CH; Alvarez RH; Valero V; Shen Y; Ueno NT
    JAMA Oncol; 2015 Dec; 1(9):1311-8. PubMed ID: 26402167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anthracycline versus nonanthracycline adjuvant therapy for early breast cancer: A systematic review and meta-analysis.
    Ding W; Li Z; Wang C; Dai J; Ruan G; Tu C
    Medicine (Baltimore); 2018 Oct; 97(42):e12908. PubMed ID: 30335021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis.
    Pathak N; Sharma A; Elavarasi A; Sankar J; Deo SVS; Sharma DN; Mathur S; Kumar S; Prasad CP; Kumar A; Batra A
    Breast; 2022 Aug; 64():7-18. PubMed ID: 35462344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy for children with medulloblastoma.
    Michiels EM; Schouten-Van Meeteren AY; Doz F; Janssens GO; van Dalen EC
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006678. PubMed ID: 25879092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Taxane containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes J; Donoghue E
    Cochrane Database Syst Rev; 2003; (3):CD003366. PubMed ID: 12917963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer.
    Martin M; Mackey J; Vogel C
    Breast; 2007 Dec; 16 Suppl 2():S127-31. PubMed ID: 17923408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
    Swain SM; Tang G; Geyer CE; Rastogi P; Atkins JN; Donnellan PP; Fehrenbacher L; Azar CA; Robidoux A; Polikoff JA; Brufsky AM; Biggs DD; Levine EA; Zapas JL; Provencher L; Northfelt DW; Paik S; Costantino JP; Mamounas EP; Wolmark N
    J Clin Oncol; 2013 Sep; 31(26):3197-204. PubMed ID: 23940225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trials.
    Gyawali B; Niraula S
    Cancer Treat Rev; 2017 Nov; 60():18-23. PubMed ID: 28863313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: a systematic review.
    Trudeau M; Sinclair SE; Clemons M;
    Cancer Treat Rev; 2005 Jun; 31(4):283-302. PubMed ID: 15916855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison between doublet agents versus single agent in metastatic breast cancer patients previously treated with an anthracycline and a taxane: a meta-analysis of four phase III trials.
    Qi WX; Tang LN; He AN; Shen Z; Yao Y
    Breast; 2013 Jun; 22(3):314-9. PubMed ID: 22901442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.
    Dang C; Hudis C
    Clin Breast Cancer; 2006 Apr; 7(1):51-8. PubMed ID: 16764744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review of taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Wilcken N; Simes RJ
    Br J Cancer; 2005 Aug; 93(3):293-301. PubMed ID: 16052223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
    Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: A meta-analysis.
    Chen Y; Shi XE; Tian JH; Yang XJ; Wang YF; Yang KH
    Medicine (Baltimore); 2018 May; 97(20):e10634. PubMed ID: 29768327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
    Ellis P; Barrett-Lee P; Johnson L; Cameron D; Wardley A; O'Reilly S; Verrill M; Smith I; Yarnold J; Coleman R; Earl H; Canney P; Twelves C; Poole C; Bloomfield D; Hopwood P; Johnston S; Dowsett M; Bartlett JM; Ellis I; Peckitt C; Hall E; Bliss JM; ;
    Lancet; 2009 May; 373(9676):1681-92. PubMed ID: 19447249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Taxane-based regimens as adjuvant treatment for breast cancer: a retrospective study in egyptian cancer patients.
    Azim HA; Abdal-Kader YS; Mousa MM; Malek RA; Abdalmassih MK; Ibrahim NY
    Asian Pac J Cancer Prev; 2015; 16(1):65-9. PubMed ID: 25640392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials.
    Niraula S; Gyawali B
    Breast Cancer Res Treat; 2019 Jan; 173(1):103-109. PubMed ID: 30238273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials.
    Natori A; Ethier JL; Amir E; Cescon DW
    Eur J Cancer; 2017 May; 77():40-47. PubMed ID: 28355581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.